Y10S 530/839
Nerves
Official title: Nerves; brain
Y10S530/839 (Nerves) appears on 114 US grants and 19 published applications in this corpus.
Search patents in Y10S- Granted patents
- 114
- Published applications
- 19
- Assignees
- 74
- Inventors
- 172
- Latest grant
- 19 Apr 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 18 | 0 |
| 1998 | 11 | 0 |
| 1999 | 14 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 2 |
| 2002 | 4 | 2 |
| 2003 | 2 | 3 |
| 2004 | 0 | 1 |
| 2005 | 2 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 2 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders19 Apr 2016US 9,315,569 B2BioArctic Neuroscience AB
- Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders19 Aug 2014US 8,809,506 B2BioArctic Neuroscience AB
- Use of neuropeptides for traumatic cartilage injury19 Apr 2011US 7,928,059 B2Wisconsin Alumni Research Foundation
- Methods for identifying substances for the treatment of Alzheimer's disease15 Feb 2011US 7,888,066 B2Mount Sinai School of Medicine
- Modulators and modulation of the interaction between RGM and Neogenin10 Aug 2010US 7,771,952 B2Abott Laboratories
- Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders9 Jul 2020US 2020/0215209 A1BioArctic AB
- Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders14 Jul 2016US 2016/0199522 A1BioArctic Neuroscience AB
- Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders13 Nov 2014US 2014/0335088 A1BioArctic Neuroscience AB
- Modulators and modulation of the interaction between rgm and neogenin25 Apr 2013US 2013/0101605 A1
- Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders3 Mar 2011US 2011/0052498 A1BioArctic Neuroscience AB
Most cited
By later US patents
- Controlled release formulations of trophic factors in ganglioside-lipsome vehicle653US 5,073,543 AG. D. Searle & Co. · 1991
- Composition for sustained release of human growth hormone152US 5,654,010 AAlkermes, Inc. · 1997
- Composition for sustained release of human growth hormone123US 5,667,808 AAlkermes, Inc. · 1997
- Antibodies to dense microspheres94US 5,231,170 A1993
- Human Notch and Delta binding domains in toporythmic proteins, and methods based thereon87US 5,648,464 AYale University · 1997